Bone Biologics Corp Intellectual Property Contracts & Agreements

8 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Third Amendment to Amended and Restated Exclusive License Agreement between The Regents of the University of California and Bone Biologics Corporation
License Agreements
Bone Biologics Corp
Biotechnology
2022
First Amendment to the Amended and Restated License Agreement dated August 13, 2020 between the Company and the Regents of the University of California
License Agreements
Bone Biologics Corp
Biotechnology
2021
First Amendment to the Amended and Restated License Agreement dated August 13, 2020 between the Company and the Regents of the University of California
License Agreements
Bone Biologics Corp
Biotechnology
2021
Amended and Restated Exclusive License Agreement, dated as of March 21, 2019, by and between the Company and The Regents of the University of California
License Agreements
Bone Biologics Corp
Biotechnology
CA
2019
Amended and Restated Exclusive License Agreement between The Regents of the University of California and Bone Biologics Corporation
License Agreements
Bone Biologics Corp
Biotechnology
CA
2017
Tenth Amendment to Exclusive License Agreement between The Regents of the University of California and Bone Biologics Corporation
License Agreements
Bone Biologics Corp
Biotechnology
2016
Ninth Amendment to Exclusive License Agreement between The Regents of the University of California and Bone Biologics Corporation
License Agreements
Bone Biologics Corp
Biotechnology
2015
Exclusive License Agreement Between The Regents of the University of California and Bone Biologics, Inc. for NELL-1 and NELL-2 Technologies
License Agreements
Bone Biologics Corp
Biotechnology
CA
2014